April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
Mar 5, 2025, 08:16

Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia

Fadi Haddad, Assistant Professor at The University of Texas MD Anderson Cancer Center, shared a paper Jennifer R. Brown and colleagues authored on X:

“AMPLIFY Ph 3 trial

867 patients, median age 61 yrs, ND CLL

No TP53/del17p, unmutated IGHV 59%

Acala+Ven x1 yr (AV) AV x1 yr + Obin x6 mo (AVO) Chemo-immunotherapy (CT)

3-year PFS: 77% AV versus 83% AVO versus 67% CT.”

Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia

Authors: Jennifer R. Brown et al.

Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia